New Progress of Clinical Application of Nicorandil in the Treatment of Coronary Heart Disease
Download PDF


Coronary heart disease
Clinical application



Submitted : 2024-03-17
Accepted : 2024-04-01
Published : 2024-04-16


Nicorandil (NIC) is a calcium channel blocker, which has been widely used in the treatment of coronary heart disease (CHD). Although NIC has shown good efficacy and safety clinically, there are still some unresolved issues with its therapeutic mechanism and pathway of action. Studies in recent years have shown that the clinical application of NIC in the treatment of CHD has made new progress, such as being widely used in stable angina pectoris (AP), myocardial infarction, and percutaneous coronary intervention (PCI). In this article, we discuss the new progress of NIC in the treatment of CHD.


Hu S, Zhang C, Zhang C, et al., 2017, Effects of Nicorandil Intravenous Pre-injection on Cerebral Blood Flow and Neurological Function in Cardiopulmonary Resuscitation Rats. Shandong Medicine, 57(38): 34–37.

Shi X, Shi M, Peng S, 2020, Study on the Anti-Apoptotic Effect of Nicorandil on Hypoxic/Reoxygenated Cardiomyocytes Through the Phosphatidylinositol-3 Kinase Pathway. Journal of Clinical Internal Medicine, 37(11): 802–805.

Gao W, 2022, Clinical Effect and Safety Analysis of Nicorandil in the Treatment of Stable Angina Pectoris. Chinese Modern Drug Application, 16(10): 110–112.

Ji Y, 2022, Observation on the Curative Effect of Rosuvastatin Combined with Nicorandil in the Treatment of Elderly Patients with Acute Non-ST-Segment Elevation Myocardial Infarction. Exploration of Rational Drug Use in China, 19(4): 49–53.

Li L, Liu X, Li Q, et al., 2022, Effects of Preoperative Intracoronary Injection of Nicorandil on Postoperative Myocardial Blood Perfusion Level and Cardiac Function in Patients with Acute Myocardial Infarction. Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, 22(1): 24–28.

Zhan P, Huang Q, Wang Y, et al., 2021, The Effect of Nicorandil on the Prognosis of Elderly Patients with Cardiac Arrest After Acute Myocardial Infarction. Chinese Journal of Gerontology, 41(1): 19–22.

Tian W, Lian Y, 2021, The Effect of Nicorandil in the Treatment of Elderly Patients with Unstable Angina Pectoris. Chinese And Foreign Medical Research, 19(22): 25–28.

Yu X, 2022, Study on the Effect of Nicorandil on the Clinical Effect and Platelet Activation of Patients with Unstable Angina Pectoris. Diabetes World, 2022(7): 134–135.

Li X, Li X, Qiao X, et al., 2021, Effects of Recombinant Human Brain Natriuretic Peptide Combined with Nicorandil on Cardiac Function and Serum Levels of Nitric Oxide and Endothelin in Patients with Ischemic Heart Failure. Chinese Hospital Medicine Evaluation and Analysis, 21(1): 38–40 + 44.

Liu Q, 2020, Analysis of the Improvement Effect of Intracoronary Injection of Nicorandil on Slow Blood Flow During Percutaneous Coronary Intervention. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 8(12): 54–55.

Gong Y, Liang M, Zhao J, et al., 2021, Effect of Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients with Coronary Heart Disease After Coronary Intervention. Chinese Journal of Molecular Cardiology, 21(5): 4232–4235.